Perioperative plasma F2-isoprostane levels correlate with markers of impaired ventilation in infants with single-ventricle physiology undergoing stage 2 surgical palliation on the cardiopulmonary bypass

Pediatric Cardiology

Volumn 33, Issue 4, 2012, Pages 562-568

  Albers, Erin ^a   Donahue, Brian S ^a   Milne, Ginger ^a   Saville, Benjamin R ^a   Wang, Wenli ^a   Bichell, David ^a   McLaughlin, Bethann ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiopulmonary bypass; Congenital heart disease; Isoprostanes; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; CARBON DIOXIDE; ISOPROSTANE DERIVATIVE;

ARTICLE; BIDIRECTIONAL CAVOPULMONARY ANASTOMOSIS; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CAVOPULMONARY CONNECTION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DISEASE MARKER; FEMALE; HEART SINGLE VENTRICLE; HUMAN; INFANT; LUNG COMPLIANCE; LUNG FUNCTION; LUNG INJURY; LUNG PERFUSION; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PALLIATIVE THERAPY; PERIOPERATIVE PERIOD; PULMONARY DYSFUNCTION; REOPERATION; BLOOD; COMPARATIVE STUDY; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; EXTRACORPOREAL CIRCULATION; FOLLOW UP; HEART VENTRICLE; LUNG FUNCTION TEST; MASS SPECTROMETRY; METHODOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RESPIRATORY FAILURE;

BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; F2-ISOPROSTANES; FOLLOW-UP STUDIES; HEART BYPASS, RIGHT; HEART DEFECTS, CONGENITAL; HEART VENTRICLES; HUMANS; INFANT; MASS SPECTROMETRY; OXIDATIVE STRESS; PALLIATIVE CARE; PERIOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY;

EID: 84863500009     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-012-0166-2     Document Type: Article

References (29)

1. Agarwal HS, Churchwell KB, Doyle TP, Christian KG, Jr. Drinkwater DC, Byrne DW, Taylor MB (2006) Inhaled nitric oxide use in bidirectional Glenn anastomosis for elevated Glenn pressures. Ann Thorac Surg 81:1429-1434
2. Angdin M, Settergren G, Starkopf J, Zilmer M, Zilmer K, Vaage J (2003) Protective effect of antioxidants on pulmonary endothelial function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17:314-320 (Pubitemid 36775846)
3. Apostolakis EE, Koletsis EN, Baikoussis NG, Siminelakis SN, Papadopoulos GS (2010) Strategies to prevent intraoperative lung injury during cardiopulmonary bypass. J Cardiothorac Surg 5:1
4. Baker WL, Anglade MW, Baker EL, White CM, Kluger J, Coleman CI (2009) Use of N-acetylcysteine to reduce postcardiothoracic surgery complications: a meta-analysis. Eur J Cardiothorac Surg 35:521-527
5. Caputo M, Mokhtari A, Rogers CA, Panayiotou N, Chen Q, Ghorbel MT, Angelini GD, Parry AJ (2009) The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing open cardiac surgery: a randomized controlled trial. J Thorac Cardiovasc Surg 138:206-214
6. Cavalca V, Sisillo E, Veglia F, Tremoli E, Cighetti G, Salvi L, Sola A, Mussoni L, Biglioli P, Folco G, Sala A, Parolari A (2006) Isoprostanes and oxidative stress in off-pump and on-pump coronary bypass surgery. Ann Thorac Surg 81:562-567 (Pubitemid 43120556)
7. Christen S, Finckh B, Lykkesfeldt J, Gessler P, Frese-Schaper M, Nielsen P, Schmid ER, Schmitt B (2005) Oxidative stress precedes peak systemic inflammatory response in pediatric patients undergoing cardiopulmonary bypass operation. Free Radic Biol Med 38:1323-1332 (Pubitemid 40602834)
8. Clancy RR (2008) Neuroprotection in infant heart surgery. Clin Perinatol 35:809-821, viii
9. Hoskote A, Li J, Hickey C, Erickson S, Van Arsdell G, Stephens D, Holtby H, Bohn D, Adatia I (2004) The effects of carbon dioxide on oxygenation and systemic, cerebral, and pulmonary vascular hemodynamics after the bidirectional superior cavopulmonary anastomosis. J Am Coll Cardiol 44:1501-1509 (Pubitemid 39303956)
10. Huang H, Yao T, Wang W, Zhu D, Zhang W, Chen H, Fu W (2003) Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass. Ann Thorac Surg 76:136-140 (Pubitemid 36819729)
11. Janssen LJ (2008) Isoprostanes and lung vascular pathology. Am J Respir Cell Mol Biol 39:383-389
12. Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brot N, Fitzgerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ 2nd, Rokach J, Shigenaga MK, Sohal RS, Sun J, Tice RR, Van Thiel DH, Wellner D, Walter PB, Tomer KB, Mason RP, Barrett JC (2005) Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 38:698-710 (Pubitemid 40249740)
13. Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, Dupuis JY, Fremes SE, Kent B, Laflamme C, Lamy A, Legare JF, Mazer CD, McCluskey SA, Rubens FD, Sawchuk C, Beattie WS (2009) Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 119:495-502
14. Keenan HT, Thiagarajan R, Stephens KE, Williams G, Ramamoorthy C, Lupinetti FM (2000) Pulmonary function after modified venovenous ultrafiltration in infants: a prospective, randomized trial. J Thorac Cardiovasc Surg 119:501-505; discussion 506-507
15. Liu T, Stern A, Roberts LJ, Morrow JD (1999) The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid. J Biomed Sci 6:226-235 (Pubitemid 29339738)
16. Madhok AB, Ojamaa K, Haridas V, Parnell VA, Pahwa S, Chowdhury D (2006) Cytokine response in children undergoing surgery for congenital heart disease. Pediatr Cardiol 27:408-413 (Pubitemid 44222391)
17. Milne GL, Sanchez SC, Musiek ES, Morrow JD (2007) Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc 2:221-226 (Pubitemid 47040087)
18. Milne GL, Yin H, Morrow JD (2008) Human biochemistry of the isoprostane pathway. J Biol Chem 283:15533-15537
19. Morrow JD, Roberts LJ II (1999) Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol 300:3-12 (Pubitemid 28500576)
20. Morrow JD, Roberts LJ (2002) The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 166:S25-S30 (Pubitemid 36015933)
21. Morrow JD, Chen Y, Brame CJ, Yang J, Sanchez SC, Xu J, Zackert WE, Awad JA, Roberts LJ (1999) The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation. Drug Metab Rev 31:117-139 (Pubitemid 29106654)
22. Ng CS, Wan S, Yim AP, Arifi AA (2002) Pulmonary dysfunction after cardiac surgery. Chest 121:1269-1277 (Pubitemid 34280453)
23. Ovechkin AV, Lominadze D, Sedoris KC, Robinson TW, Tyagi SC, Roberts AM (2007) Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions. Arch Physiol Biochem 113:1-12 (Pubitemid 46825684)
24. Ramlawi B, Rudolph JL, Mieno S, Khabbaz K, Sodha NR, Boodhwani M, Levkoff SE, Marcantonio ER, Sellke FW (2006) Serologic markers of brain injury and cognitive function after cardiopulmonary bypass. Ann Surg 244:593-601
25. discussion 1172-1163
26. Stayer SA, Diaz LK, East DL, Gouvion JN, Vencill TL, McKenzie ED, Fraser CD, Andropoulos DB (2004) Changes in respiratory mechanics among infants undergoing heart surgery (table of contents). Anesth Analg 98:49-55 (Pubitemid 38029840)
27. Ulus AT, Aksoyek A, Ozkan M, Katircioglu SF, Basu S (2003) Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans. Free Radic Biol Med 34:911-917 (Pubitemid 36316075)
28. Warren OJ, Smith AJ, Alexiou C, Rogers PL, Jawad N, Vincent C, Darzi AW, Athanasiou T (2009) The inflammatory response to cardiopulmonary bypass: part 1-mechanisms of pathogenesis. J Cardiothorac Vasc Anesth 23:223-231
29. Warren OJ, Watret AL, de Wit KL, Alexiou C, Vincent C, Darzi AW, Athanasiou T (2009) The inflammatory response to cardiopulmonary bypass: part 2-antiinflammatory therapeutic strategies. J Cardiothorac Vasc Anesth 23:384-393